Company intelligence / Profile preview

Euromi Biosciences

Hauts-de-France, Franceeuromi-biosciences.com ↗

Ownership: Private
Development stage: Commercial

Overview

Euromi Biosciences manufactures and markets CE-marked silicone gel-filled breast implants under the Cereform® brand. The company leverages over 25 years of group experience in medical, aesthetic, and plastic surgery devices. Their products are ISO 13485 certified for quality management systems.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Cereform

Commercial

Indications: Breast augmentation, Breast reconstruction

Beyond the preview

Go deeper on Euromi Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euromi Biosciences.

Explore the full profile